Literature DB >> 15257316

Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours.

Monika Korabiowska1, Thilo Schlott, Nils Siems, Anegret Müller, Carlos Cordon-Cardo, Gösta Fischer, Ulrich Brinck.   

Abstract

Adenomatous polyposis coli gene (APC) defects have been demonstrated for the first time in familial adenomatous polyposis. Recent reports indicate that the APC gene is an intermediary between cell adhesion molecules and the cytoskeleton and that it may function as a gatekeeper of colonic epithelial proliferation. The objective of this study was to analyse APC's presence in lentigos, primary melanomas and melanoma metastases. By immunohistochemistry, APC was demonstrated in all lentigos, in 75 out of 88 primary melanomas and in 16 out of 28 melanoma lymphatic metastases. The percentage of immunolabelled tumour cells (APC index) in lentigos ranged between 5 and 69%, in primary melanomas between 0 and 98% and in melanoma metastases between 0 and 52%. Statistically significant differences between lentigos and primary melanomas and between lentigos and metastases in APC expression were found. In a multivariate analysis, APC showed an independent prognostic impact. Analysis of microsatellite instability in the APC locus was performed on 29 melanomas. Microsatellite instability was found in 5/29 melanomas and loss of heterozygosity in 1/29 melanomas. Promoter methylation of APC was found in 6/10 APC-negative primary melanomas and in 9/10 APC-negative melanoma lymphatic metastases investigated. We conclude about important role of APC alterations for melanoma progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257316     DOI: 10.1038/modpathol.3800238

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

Review 1.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

2.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

3.  E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.

Authors:  Vicente A Torres; Julio C Tapia; Diego A Rodriguez; Alvaro Lladser; Cristian Arredondo; Lisette Leyton; Andrew F G Quest
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

Review 4.  Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Bonnie E Gould Rothberg; Michael B Bracken; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

5.  Epigenetic regulation of APC in the molecular pathogenesis of gallbladder cancer.

Authors:  Dinesh Singh Tekcham; Satish S Poojary; Shushruta Bhunia; Mustafa Ahmed Barbhuiya; Sanjeev Gupta; Braj Raj Shrivastav; Pramod Kumar Tiwari
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

Review 6.  Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?

Authors:  Imène Krossa; Thomas Strub; Andrew E Aplin; Robert Ballotti; Corine Bertolotto
Journal:  Cancers (Basel)       Date:  2022-10-05       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.